|
Volumn 26, Issue 4, 1999, Pages 487-496
|
A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
ADENOCARCINOMA;
ADULT;
AGED;
ALOPECIA;
ANOREXIA;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LIVER TUMOR;
LYMPH NODE METASTASIS;
MALE;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
NAUSEA;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
STOMACH TUMOR;
VOMITING;
ADENOCARCINOMA;
ADULT;
AGED;
ALOPECIA;
ANOREXIA;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUKOPENIA;
LIVER NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NAUSEA;
PACLITAXEL;
STOMACH NEOPLASMS;
TAXOIDS;
VOMITING, ANTICIPATORY;
|
EID: 2342465869
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (77)
|
References (0)
|